Kenvue Inc. Common Stock vs Valley National Bancorp Common Stock — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while Valley National Bancorp Common Stock trades at $12.63 (market cap $7.05B). The key difference: Kenvue Inc. Common Stock is far larger — about 4.8× Valley National Bancorp Common Stock's market cap, and Kenvue Inc. Common Stock pays the higher dividend (4.74%). Which is the better fit depends on your goals.
| KVUE | VLY | |
|---|---|---|
Market Cap | $34.06B | $7.05B |
Volume | 23,267,228 | 7,669,925 |
Sector | Consumer Staples | Financials |
52-Week High | $19.83 | $15.19 |
52-Week Low | $14.11 | $9.72 |
Enterprise Value | $41.56B | $9.55B |
Dividend Yield | 4.74% | 3.45% |
Typical Hold Time | — | 1 Days |
Trailing returns across standard periods
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →Valley National Bancorp is a financial holding company whose main subsidiary is Valley National Bank. It provides commercial, retail, trust, and investment services across several U.S. states.
Read more on VLY →